PRECISION®
Report
- Report Number
- 3006630150-2011-00735
- Event Type
- Injury
- Date Received
- May 24, 2011
- Date of Event
- February 10, 2011
- Report Date
- February 10, 2011
- Manufacturer
- BOSTON SCIENTIFIC NEUROMODULATION
- Product Code
- LGW
- PMA / PMN Number
- 030017
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
DEVICE EVALUATION INDICATED THAT THE LEAD (S/N (B)(4)) PASSED MECHANICAL TESTS PERFORMED. THE COMPLAINT OF HIGH IMPEDANCE WAS CONFIRMED. THE REPORTED HIGH IMPEDANCE RESULTED FROM THE FRACTURED CABLES AT THE PROXIMAL END OF THE LEAD. THE LEAD HAD A PERMANENT BEND ON IT RIGHT AFTER IT EXITED THE IPG ON THE PROXIMAL END. THE PROXIMAL END HAS HYSOL EPOXY IN IT TO STIFFEN IT. IF AFTER INSERTION INTO THE HEADER, THE LEAD IS GIVEN A TIGHT BEND WHERE THE LEAD EXITS THE IPG, THIS PUTS QUITE A LOT OF TENSION ON THE LEAD CABLES. DEVICE ANALYSIS OF LEAD (S/N (B)(4)) AND THE IPG REVEALED BOTH DEVICES EXHIBITED NORMAL DEVICE CHARACTERISTICS.
ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: MODEL # SC-2218-50 (B)(4) DESCRIPTION: ST LINEAR LEAD, 50CM WITH PRE-LOADED 0.014 INCH STYLET MODEL # SC-1110-02 (B)(4) DESCRIPTION: IPG KIT (WITHOUT PULL-THROUGH TUNNELER).
A REPORT WAS RECEIVED THAT THE DURING A REPROGRAMMING SESSION THE PATIENT COMPLAINED OF UNCOMFORTABLE STIMULATION. X-RAYS CONFIRMED LEAD MIGRATION AND THAT 2 CONTACTS HAD HIGH IMPEDANCES. THE PHYSICIAN AND PATIENT HAVE ELECTED TO EXPLANT THE PATIENT'S DEVICE.
A REPORT WAS RECEIVED THAT THE DURING A REPROGRAMMING SESSION THE PATIENT COMPLAINED OF UNCOMFORTABLE STIMULATION. X-RAYS CONFIRMED LEAD MIGRATION AND THAT 2 CONTACTS HAD HIGH IMPEDANCES. THE PHYSICIAN AND PATIENT HAVE ELECTED TO EXPLANT THE PATIENT'S DEVICE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PRECISION® | SPINAL CORD STIMULATOR | LGW | BOSTON SCIENTIFIC NEUROMODULATION | SC-2218-50 | N/A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 25 YR | Required Intervention |